Steven M Smith, PharmD, MPH, FCCP, FAHA

Steven Smith is an Assistant Professor and Interim Chair of the Department of Pharmaceutical Outcomes and Policy, with a joint appointment in the Division of Cardiovascular Medicine (College of Medicine). He also serves as Co-Director for the UF Center for Integrative Cardiovascular and Metabolic Diseases.

He received his PharmD degree from the University of Florida College of Pharmacy. He then completed a PGY-1 residency at the North Florida/South Georgia Veterans Health System in Gainesville, FL. After his residency, Dr. Smith completed a postdoctoral fellowship in Family Medicine during which time he participated in the Advanced Postgraduate Program in Clinical Investigation (APPCI) and concurrently completed the requirements for a Master of Public Health. Dr. Smith joined the faculty at the University of Colorado in 2011. He returned to the University of Florida in 2014.

Dr. Smith’s research is in the area of cardiovascular pharmacotherapy, in particular hypertension and cardiometabolic disease, and is funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health and the U.S. Department of Defense. He is an elected Fellow in the American Heart Association and the American College of Clinical Pharmacy, as well as a member of the American College of Cardiology, American Association of Colleges of Pharmacy and the International Society for Pharmacoepidemiology. He also has served in several leadership roles nationally, including on the Examination Committee for the American Society of Hypertension Specialists’ Program (ASHSP) Certified Hypertension Clinician program, in several initiatives through the American Heart Association Hypertension Council, on the Board of Directors for the Consortium for Southeastern Hypertension Control (2019-2023 term), and as a founding member of the CDC’s National Hypertension Control Roundtable.

Dr. Smith teaches a course on Pharmacoepidemiology & Drug Safety in the 3rd year of the PharmD program, and co-coordinates a graduate course on Measurement in Pharmaceutical Outcomes Research.

From 2014 to 2023, Dr. Smith also co-directed the UF Family Medicine Pharmacy Fellowship.

• Board-Certified Pharmacotherapy Specialist

  Board of Pharmaceutical Specialties
• Certified Hypertension Clinician

  American Hypertension Specialist Certification Program

Dr. Smith’s research lab focuses on understanding and improving use of cardiovascular-related drug therapy in the real world to reduce risk of major adverse outcomes at the population level. Hypertension and its treatment are the major area of focus, and Dr. Smith has particular expertise in the area of difficult-to-control, or ‘resistant’ hypertension.

His lab employs a variety of observational methodologic approaches and data sources, including EHR, administrative claims, and prospective cohort and randomized clinical trial data. Strong collaborations within the College of Pharmacy include with faculty and trainees in the Cardiovascular group of the Department of Pharmacotherapy and Translational Research, as well as with the Department of Pharmaceutical Outcomes and Policy and the Center for Drug Evaluation and Safety. Outside of the College, Dr. Smith’s group works closely with the Division of Cardiovascular Medicine and the Center for Integrative Cardiovascular and Metabolic Diseases, where Dr. Smith serves as Associate Director.

Current funding for the lab is through the National Heart, Lung and Blood Institute (studying what drives antihypertensive prescribing and how to optimize early therapy; studying antihypertensive prescribing cascades; and, studying apparent treatment-resistant hypertension in the All-of-Us program), PCORI (hypertension surveillance through the BP Control Lab), and the U.S. Department of Defense (the WARRIOR trial).

• Cardiometabolic Disease
• Cardiovascular Epidemiology
• Hypertension
• Pharmacoepidemiology
• Resistant Hypertension

0000-0002-0201-839X